Catalyst Biosciences Inc Stock
Catalyst Biosciences Inc Stock
Currently there is a rather positive sentiment for Catalyst Biosciences Inc with 5 Buy predictions and 0 Sell predictions.
With a target price of 22 € there is potential for a 4134.84% increase which would mean more than doubling the current price of 0.52 € for Catalyst Biosciences Inc.
Our community identified positive and negative aspects for Catalyst Biosciences Inc stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Catalyst Biosciences Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Catalyst Biosciences Inc in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Catalyst Biosciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Catalyst Biosciences Inc | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | -0.960% | 18.330% | -4.017% | -62.347% | 18.330% | -29.781% | -91.538% |
| Pacira Pharmaceuticals | - | 1.852% | 8.911% | 24.294% | 1.852% | -36.416% | -60.714% |
| Twist Bioscience Corp | 3.320% | 7.038% | 7.578% | -31.785% | 7.038% | 23.976% | -78.241% |
Comments
Crescent Biopharma (NASDAQ:CBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Show more
Ratings data for CBIO provided by MarketBeat
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $26.00 price target on the stock.
Show more
Ratings data for CBIO provided by MarketBeat
Crescent Biopharma, Inc. (NASDAQ: CBIO) is now covered by analysts at Wedbush. They set an "outperform" rating and a $27.00 price target on the stock.
Show more
Ratings data for CBIO provided by MarketBeat